Consumer health in Greece continues to see healthy retail current value growth in 2024. While retail volume sales are under pressure, inflationary pressure remains high on prices. While the extent of price increases varies by brand, most products have experienced rises in retail selling prices. Interestingly, most categories have not seen major changes in consumer behaviour, despite inflationary pressures, as brand loyalty remains strong. However, price hikes have affected spending on vitamins a...
Euromonitor International's Consumer Health in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Greece
Euromonitor International
September 2024
List Of Contents And Tables
CONSUMER HEALTH IN GREECE
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN GREECE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Price hikes continue in 2024
Mild winter hinders demand
Algofren and Nurofen compete fiercely in ibuprofen
PROSPECTS AND OPPORTUNITIES
Topical analgesics continue to attract investment
Low availability of and exposure to generics favours brands
Competition with Rx products is set to remain strong
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GREECE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Mild winter influences category performance
The product variety is rising amidst strong investments
Price increases remain high in 2024
PROSPECTS AND OPPORTUNITIES
Weather to inform category performance
Levels of self-medication to remain high, but increase in flu vaccinations to hinder growth potential
Nasal sprays to continue to dominate decongestants
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN GREECE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Key withdrawal leads to changes in the competitive landscape of antacids
Higher use of probiotics and return to travel norms inform demand trends
Price hikes lead to strong retail value growth
PROSPECTS AND OPPORTUNITIES
Rise in anxiety and stress levels create growth potential
Changes in diet and nutrition habits to hamper need for digestive remedies
Delivery formats to drive development
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN GREECE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Price increases underpin retail value growth
Unfavourable circumstances for retail volume growth
Competition with herbal/traditional dermatologicals affects standard products’ performance
PROSPECTS AND OPPORTUNITIES
Changes in marketing are set to gather pace as self-medication rises
Climate and demographics to continue to shape trends
E-commerce to continue to gain retail value share
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN GREECE
KEY DATA FINDINGS
2024 DEVELOPMENTS
High retail price is an obstacle to retail volume growth
Nicorette remains the sole brand
Competition with new generation tobacco products remains high
PROSPECTS AND OPPORTUNITIES
Pricing to continue to hinder demand
No significant new competitor is expected to emerge
Smoking prevalence is decreasing
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN GREECE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Demand rises as more consumers feel the need for sleep aids
Strong investment contributes to higher awareness and growth